Intuitive Surgical, Inc. $ISRG Holdings Lifted by Triodos Investment Management BV

Triodos Investment Management BV grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% during the second quarter, Holdings Channel reports. The institutional investor owned 91,237 shares of the medical equipment provider’s stock after purchasing an additional 1,250 shares during the quarter. Intuitive Surgical accounts for 3.7% of Triodos Investment Management BV’s holdings, making the stock its 6th largest holding. Triodos Investment Management BV’s holdings in Intuitive Surgical were worth $49,579,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in ISRG. Aaron Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 0.8% in the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after purchasing an additional 19 shares during the period. Crown Wealth Group LLC raised its stake in Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock valued at $218,000 after buying an additional 20 shares during the last quarter. FSM Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 3.8% in the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock worth $270,000 after acquiring an additional 20 shares in the last quarter. CFO4Life Group LLC boosted its holdings in Intuitive Surgical by 4.8% in the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock worth $216,000 after acquiring an additional 20 shares in the last quarter. Finally, J. W. Coons Advisors LLC boosted its holdings in Intuitive Surgical by 1.4% in the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock worth $741,000 after acquiring an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on ISRG. Piper Sandler reissued an “overweight” rating and issued a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Royal Bank Of Canada reissued an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a report on Tuesday, August 19th. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a report on Wednesday. Wells Fargo & Company boosted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a report on Wednesday, July 23rd. Finally, Evercore ISI dropped their target price on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a report on Tuesday. Fourteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $589.43.

Intuitive Surgical Price Performance

ISRG stock opened at $443.76 on Friday. The stock has a market capitalization of $159.08 billion, a P/E ratio of 61.89, a P/E/G ratio of 4.71 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The business has a fifty day moving average price of $459.75 and a 200-day moving average price of $498.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.78 earnings per share. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director owned 739 shares of the company’s stock, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.